Product innovations > Product brochure

Contract Services Case Study

Format - PDF file
Published - 01-Sep-2007
Size - 505.75 kB

Baxter's contract services case study details the expedited transfer of a commercial launched lyophilized drug to a new production site. Their team designed solutions resulting in cost savings, yield improvement and cycle optimization.

Pfizer outsources oncology drug sales in China

01-Jul-2008 - Pfizer has enlisted outsourcing services firm NovaMed Pharmaceuticals to conduct the distribution, sales and marketing of some of its products in the country.

Baxter uses cell culture for H5N1 vaccine

17-Jun-2008 - Baxter has successfully produced H5N1 influenza vaccine in African green monkey kidney cells in quantities sufficient for clinical testing, according to an article published in The New England Journal of Medicine.

Pharmaceutical manufacturing: people on the move

12-Jun-2008 - in-PharmaTechnologist.com presents its periodic round-up of personnel changes in pharmaceutical manufacturing and development.

Hospira faces $35m charge over Morgan Hill plans

12-May-2008 - The decision to end manufacturing operations at its facility in Morgan Hill, California in the next three years may cost Hospira up to $35m (€22.7m), according to a document the firm filed with the US Securities and Exchange Commission (SEC).

Sweden recalls Sanofi's enoxaparin after OSCS contamination

30-Apr-2008 - Swedish authorities have recalled Sanofi Aventis' low molecular weight injectable blood thinner Lovenox (enoxaparin), known locally as Klexane, after four batches of the blockbuster drug were found to contain oversulfated chondroitin sulphate.

FDA links contaminant to adverse events: issues warning to China facility

24-Apr-2008 - The US Food and Drug Administration (FDA) has revealed evidence linking the heparin contaminant with the series of reported adverse reactions, and has also now issued a warning letter to the Chinese facility at the centre of the safety scare after completing its inspection.

FDA suspects heparin contamination due to fraud

17-Apr-2008 - The US Food and Drug Administration (FDA) believes that the contamination of Baxter's blood thinner heparin, which has been linked to 62 deaths in the US, may have been due to the deliberate replacement of some ingredients with cheaper alternatives.

Heparin death tally worsens; FDA issues device warning

14-Apr-2008 - The number of people whose deaths are associated with an allergic reaction to heparin has shot up as the US Food and Drug Administration (FDA) has updated its tally.

China watchdog responds to heparin scare; AZ now affected

30-Mar-2008 - China's drug regulatory authority is finally responding to curb its damaged reputation by urging its local authorities to take a more proactive role in stemming what is fast becoming a global heparin contamination, sparked by material sourced in the country.

Heparin scare spreads in Europe

27-Mar-2008 - France, Italy, and Denmark are the latest countries to recall heparin products as the contamination scare spreads over materials linked to China.

Featured Suppliers

Contract Services Case Study

01-Sep-2007 -

PDF file - 505.75 kB

Firstname*
Lastname*
Email*
Job Function*
Activity Profile*
Company*
Employees*
Country*
State
Stay informed on the latest product and market innovations similar to this product.*	YesNo